eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2018
vol. 43
 
Share:
Share:
abstract:
Clinical immunology

Neurodegenerative changes detected by neuroimaging in a patient with contiguous X-chromosome deletion syndrome encompassing BTK and TIMM8A genes

Anna Szaflarska
,
Magdalena Rutkowska-Zapała
,
Anna Gruca
,
Katarzyna Szewczyk
,
Mirosław Bik-Multanowski
,
Marzena Lenart
,
Marta Surman
,
Ilona Kopyta
,
Ewa Głuszkiewicz
,
Magdalena Machnikowska-Sokołowska
,
Katarzyna Gruszczyńska
,
Anna Pituch-Noworolska
,
Maciej Siedlar

(Centr Eur Immunol 2018; 43 (2): 139-147)
Online publish date: 2018/06/30
View full text Get citation
 
PlumX metrics:
Introduction
In this study we describe a patient with gross deletion containing the BTK and TIMM8A genes. Mutations in these genes are responsible for X-linked agammaglobulinemia and Mohr-Tranebjaerg syndrome, respectively. X linked agammaglobulinemia is a rare primary immunodeficiency characterized by low levels of B lymphocytes and recurrent microbial infections, whereas, Mohr-Tranebjaerg syndrome is a progressive neurodegenerative disorder with early onset of sensorineural deafness.

Material and methods
For neuroimaging, the magnetic resonance imaging and magnetic resonance spectroscopy of the brain were performed. Microarray analysis was performed to establish the extent of deletion.

Results
The first clinical symptoms observed in our patient at the age of 6 months were connected with primary humoral immunodeficiency, whereas clinical signs of MTS emerged in the third year of live. Interestingly, the loss of speech ability was not accompanied by hearing failure. Neuroimaging of the brain suggested leukodystrophy. Molecular tests revealed contiguous X-chromosome deletion syndrome encompassing BTK (from exons 6 through 19) and TIMM8A genes. The loss of the patient’s DNA fragment was accurately localized from 100 601 727 to 100 617 576 bp on chromosome’s loci Xq22.1.

Conclusions
We diagnosed XLA-MTS in the first Polish patient on the basis of particular molecular methods. We detected neurodegenerative changes in MRI and MR spectroscopy in this patient. Our results provide further insight into this rare syndrome.

keywords:

neuroimaging, X-linked agammaglobulinemia, Mohr-Tranebjaerg syndrome, Vanishing white matter leukodystrophy, BTK, TIMM8A

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.